What are the symptoms and treatment options for an older adult with a history of hypertension and smoking, presenting with a 5 mm focal outpouching at an infrarenal penetrating atherosclerotic ulcer?

Management of 5 mm Infrarenal Penetrating Atherosclerotic Ulcer

Clinical Presentation and Symptoms

Patients with infrarenal penetrating atherosclerotic ulcers typically present with chronic abdominal or back pain, though many cases are discovered incidentally on imaging. 1

Key Symptoms to Assess:

• Abdominal or lumbar pain is the most common presenting symptom, occurring in approximately 75% of symptomatic cases 2, 3, 4
• New-onset or worsening pain indicates PAU expansion involving the tunica adventitia and signals impending rupture requiring urgent intervention 1, 5
• Many patients are asymptomatic, with PAU discovered incidentally during imaging for other conditions 1, 3
• The classic triad of abdominal/back pain, pulsatile mass, and hypotension suggests rupture and requires immediate surgical evaluation 1

Patient Risk Profile:

• Typical patient: male, >65 years old, smoker with multiple comorbidities 1, 5
• Associated conditions: hypertension (universal), coronary artery disease, COPD, renal insufficiency 1, 4

---

Immediate Management Protocol

All patients with PAU require immediate aggressive medical therapy with intravenous beta-blockers targeting heart rate ≤60 bpm and systolic blood pressure <120 mmHg, regardless of symptoms or PAU size. 1, 5, 6

Hemodynamic Control (Class I Recommendation):

1. First-line: IV beta-blockers to achieve heart rate ≤60 bpm 5, 6
2. Alternative (if beta-blockers contraindicated): Non-dihydropyridine calcium channel blockers 5
3. Critical pitfall: Never initiate vasodilators before heart rate control, as this provokes reflex tachycardia and increases aortic wall stress 5, 6
4. After heart rate control: Add IV ACE inhibitors/vasodilators if systolic BP remains >120 mmHg 5
5. Adequate analgesia is essential 6

---

Diagnostic Confirmation and Risk Stratification

Contrast-enhanced CT is the diagnostic technique of choice with 96% sensitivity for detecting associated intramural hematoma. 5, 6

Imaging Findings:

• Classic appearance: "Mushroom-shaped protrusion" with overhanging edges penetrating the internal elastic lamina 5, 6
• PAU dimensions: Typically 5-25 mm diameter, 4-30 mm depth 1
• Associated findings: Intramural hematoma, periaortic hematoma, pleural effusion 1

High-Risk Features Requiring Intervention:

Your 5 mm PAU requires assessment for these features 5, 6:

• Maximum PAU width ≥13-20 mm
• Maximum PAU depth ≥10 mm
• Growth of width or depth >5 mm/year
• Associated saccular aneurysm
• Increasing pleural effusion
• Persistent or recurrent pain despite medical therapy

---

Treatment Strategy for Infrarenal (Type B) PAU

For uncomplicated infrarenal PAU without high-risk features, initial medical therapy under careful surveillance is recommended (Class I). 1, 6

Your 5 mm PAU Management:

If Asymptomatic and No High-Risk Features:

• Conservative management with strict medical therapy 1, 6
• Surveillance imaging protocol: CT or MRI at 1 month, then 3,6, and 12 months, then annually if stable 5, 6
• Monitor for expansion: Growth >5 mm/year mandates intervention 5

If Symptomatic OR High-Risk Features Present:

• Endovascular treatment (EVAR) is recommended as first-line therapy (Class I) 1, 6, 3, 4
• Infrarenal PAU is particularly amenable to endovascular repair due to localized nature and suitable anatomy 3, 4
• Technical success rates are excellent with standard aorto-biiliac stent-graft configuration 3, 4

Indications for Urgent Intervention:

• Persistent/recurrent pain despite medical therapy 1, 6
• Contained rupture with extraaortic hematoma 4
• Associated aneurysm formation (your patient has 5 mm outpouching) 4
• Progressive enlargement on serial imaging 2, 3

---

Long-Term Medical Management

All patients require indefinite strict blood pressure control and cardiovascular risk modification regardless of intervention status. 5, 6

Mandatory Long-Term Therapy (Class I):

• Blood pressure target: Systolic <120 mmHg, diastolic <80 mmHg 5, 6
• High-intensity statin therapy: LDL-C reduction ≥50% to goal <55 mg/dL (<1.4 mmol/L) 5, 6
• Low-dose aspirin 75-162 mg daily to reduce cardiovascular events 5
• Smoking cessation with behavior modification, nicotine replacement, or bupropion 1

---

Critical Clinical Pitfalls

Common Errors to Avoid:

• Never dismiss small PAUs as benign: Even 5 mm lesions can progress to rupture, particularly in infrarenal location where rupture risk may be underestimated 2, 3
• Never delay imaging in symptomatic patients: New or worsening pain indicates expansion and impending rupture 1, 5
• Never start vasodilators before beta-blockade: This increases aortic wall stress 5, 6
• Never assume infrarenal PAU is stable without surveillance: The threshold for treatment should be low given catastrophic potential 3

Special Consideration for Infrarenal Location:

Infrarenal PAU is exceedingly rare (most PAUs occur in descending thoracic aorta), but when present, endovascular repair is highly effective and should be strongly considered even for smaller lesions given the localized nature and excellent technical outcomes. 2, 3, 4

---

Specific Recommendation for Your 5 mm Case

Given the 5 mm focal outpouching at an infrarenal PAU, immediate aggressive medical therapy is mandatory, followed by urgent CT imaging to assess for high-risk features; if any high-risk features are present OR if the patient is symptomatic, proceed directly to endovascular repair (EVAR), as infrarenal PAU has excellent outcomes with endovascular treatment and low threshold for intervention is justified given rupture risk. 1, 6, 3, 4